Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

• Status: Completed
• Trial end date: 2017-10-15
• Target enrollment: 0
• Participant gender: All

Summary

This study compared two main different induction protocols used to treat myeloma eligible patients in Brazil. VCD against CTD.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia
• Treatments: BB 1101; Bortezomib; Cyclophosphamide; Dexamethasone; Dexamethasone acetate; Thalidomide

Criteria

Inclusion Criteria:

• multiple myeloma newly diagnose elegible to autologous transplantation Patients submitted to ctd or vcd Myeloma patients newly diagnose >18yo

Exclusion Criteria:

• other chemotherapy induction protocol